Brief: Taysha Gene Therapies Reports Third Quarter Financial Results

Taysha Gene Therapies

08/11/2022 12:32

Nov 8 (Reuters) - Taysha Gene Therapies Inc  TSHA.O :
    * TAYSHA GENE THERAPIES REPORTS THIRD QUARTER 2022 FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
    * TAYSHA - $50 MILLION STRATEGIC INVESTMENT FROM ASTELLAS
PHARMA
TO SUPPORT DEVELOPMENT OF TSHA-120 IN GIANT AXONAL
NEUROPATHY,TSHA-102 IN RETT SYNDROME
    * TAYSHA GENE THERAPIES INC - AS OF SEPTEMBER 30, 2022,
COMPANY
HAD CASH AND CASH EQUIVALENTS OF $34.3 MILLION
    * TAYSHA GENE THERAPIES - EXPECTS EXISTING CASH AND CASH
EQUIVALENTS, RECEIPT OF OTHER PAYMENTS TO ENABLE CASH RUNWAY
INTO Q1 2024

Source text for Eikon:  ID:nGNXb843dC 
Further company coverage:  TSHA.O 
 ((Reuters.Briefs@thomsonreuters.com;))